Tocilizumab, an interleukin‐6 inhibitor, may ameliorate the inflammatory manifestations
associated with severe coronavirus disease 2019 (COVID‐19) and thus improve clinical …

Introduction: Corona Virus Disease 2019 (COVID-19) quarantine has been associated with
depression, anxiety, and stress symptoms. We hypothesize these symptoms might even be …

There is a lack of predictive markers for early and rapid identification of disease progression
in COVID-19 patients. Our study aims at identifying microRNAs (miRNAs)/small nucleolar …

Background There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at
a national level, and none after 60 days of follow up. The aim of this study was to describe …

Background Central nervous system (CNS) viral infections are an important cause of morbidity
and mortality. No data are available regarding their epidemiology in Qatar. Design We …

Coronavirus disease-2019 (COVID-19) was declared as a pandemic by WHO in March 2020.
SARS-CoV-2 causes a wide range of illness from asymptomatic to life-threatening. There …

Objectives To estimate the real-world effectiveness of sotrovimab against severe, critical, or
fatal COVID-19 in Qatar at a time in which most SARS-CoV-2 incidences occurred due to the …

Background and Objectives. Bacterial meningitis is a common medical condition in Qatar.
The aim of this study was to describe the clinical characteristics of bacterial meningitis, the …

Objective: Rare disease Background: Primary pituitary tuberculosis (in absence of other organ
involvement and constitutional symptoms) is an extremely rare disease with total reported …

This article reports six cases of nosocomial Acinetobacter baumannii meningitis in patients
who had undergone neurosurgical procedures with placing of external ventricular drains. The …